Aemetis, Inc. (NASDAQ:AMTX) Files An 8-K Results of Operations and Financial ConditionItem 2.02 Results of Operations and Financial Condition.
On March 29, 2018, Aemetis, Inc. (the “Company”) issued a press release announcing its earnings for the quarter and year ended December 31, 2017. Aemetis will also host an earnings review call on March 29, 2017 at 11:00 am Pacific (PT). For details on the call, visit: http://www.aemetis.com/investors/conferencecalls/.
The press release is being furnished as Exhibit 99.1 to this Current Report on Form 8K and is incorporated herein by reference.
This Form 8K and Exhibit 99.1 hereto shall be deemed “furnished” and not “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be incorporated by reference into any registration statement of the issuer.
Item 7.01 Regulation FD Material.
On March 29, 2018, the Company issued a news release, posted to its web site at www.aemetis.com, announcing its earnings for the quarter and year ended December 31, 2017, a copy of which is filed as Exhibit 99.1 hereto and incorporated herein by reference.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits.
EXHIBIT NUMBER DESCRIPTION
Exhibit99.1 Earnings Release dated March 29, 2018
AEMETIS, INC ExhibitEX-99.1 2 amtx_ex91.htm PRESS RELEASE Blueprint Exhibit 99.1 External Investor Relations Contact: Kirin Smith PCG Advisory Group (646) 863-6519 ksmith@pcgadvisory.com Company Contact: Todd Waltz Chief Financial Officer (408) 213-0925 twaltz@aemetis.com Aemetis Reports 2017 Fourth Quarter and Year-End Results CUPERTINO,…To view the full exhibit click here
About Aemetis, Inc. (NASDAQ:AMTX)
Aemetis, Inc. is an international renewable fuels and biochemicals company. The Company is focused on the production of fuels and chemicals through the acquisition, development and commercialization of technologies that replace traditional petroleum-based products by conversion of first-generation ethanol and biodiesel plants into biorefineries. Its segments include North America and India. The North America segment includes the Company’s approximately 60 million gallon per year capacity ethanol manufacturing plant in Keyes, California and its technology lab in College Park, Maryland. The India segment includes the Company’s over 50 million gallon per year capacity biodiesel manufacturing plant in Kakinada, the administrative offices in Hyderabad, India, and the holding companies in Nevada and Mauritius. The Keyes plant produces denatured ethanol, Wet Distillers Grains, corn oil and Condensed Distillers Solubles. It produces biodiesel and refined glycerin at the Kakinada plant.